Liselotte Nilsson
Vendite & Marketing presso CLINICAL LASERTHERMIA SYSTEMS AB
Posizioni attive di Liselotte Nilsson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CLINICAL LASERTHERMIA SYSTEMS AB | Vendite & Marketing | 01/01/2021 | - |
Storia della carriera di Liselotte Nilsson
Precedenti posizioni note di Liselotte Nilsson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PROSTALUND AB | Vendite & Marketing | - | - |
Svar Life Science AB
 Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | Vendite & Marketing | - | - |
| PHASE HOLOGRAPHIC IMAGING PHI AB | Vendite & Marketing | 01/11/2016 | - |
Statistiche
Distribuzione geografica
| Svezia | 5 |
Posizioni
| Sales & Marketing | 4 |
Settori
| Health Technology | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PHASE HOLOGRAPHIC IMAGING PHI AB | Health Technology |
| CLINICAL LASERTHERMIA SYSTEMS AB | Health Technology |
| PROSTALUND AB | Health Technology |
| Aziende private | 1 |
|---|---|
Svar Life Science AB
Svar Life Science AB Miscellaneous Commercial ServicesCommercial Services Svar Life Science AB is a Swedish company that provides GMP and non-GMP bioassay services for drug development. The private company is based in Malmö, Sweden. The company specializes in using activity biomarkers to determine if deficiencies, overactivation, or dysregulation in the complement system are causing or contributing to a person's disease or condition. The company offers method development, qualification, validation, and method improvements throughout the drug development lifecycle. Anne Thjømøe has been the CEO of the company since 2022. | Commercial Services |
- Borsa valori
- Insiders
- Liselotte Nilsson
- Esperienza
